Legal Opinion
Pfizer Inc. v. Mylan Pharmaceuticals Inc.
District Court, D. Delaware
Decided October 22, 2014No. C.A.No. 10-528-GMSPublishedCited by 3 opinions
1Opinion of the Court
MEMORANDUM
GREGORY M. SLEET, UNITED STATES DISTRICT JUDGE
I. INTRODUCTION
In this patent infringement action, plaintiffs Pfizer Inc., Pharmacia & Upjohn Company, Pharmacia & Upjohn Company LLC, Sugen, Inc., C.P. Pharmaceuticals International C.V., Pfizer Pharmaceuticals LLC, and PF Prism C.V. (collectively, “Pfizer”) allege that pharmaceutical products proposed by defendant Mylan Pharmaceuticals Inc. (“Mylan”) infringe the asserted claims of the patents-in-suit. (D.I.l.) The court held a four-day bench trial in this matter on November 26 through November 29, 2012. (D.I.148-151.) Presently before…
2Cases cited22 opinions
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- Colorado v. New MexicoSupreme Court of the United States · 1984
- Pfizer, Inc. v. Apotex, Inc.Court of Appeals for the Federal Circuit · 2007
- Procter & Gamble Co. v. Teva Pharmaceuticals USA, Inc.Court of Appeals for the Federal Circuit · 2009
17 more not listed; retrieve them via the Exa API.
3Cited by3 opinions
- AstraZeneca AB v. Aurobindo Pharma Ltd.District Court, D. Delaware · 2017
- United Therapeutics Corp. v. Watson Laboratories, Inc.District Court, D. Massachusetts · 2016
- FCX Solar, LLC v. FTC Solar, Inc.District Court, S.D. New York · 2022